(Q36598755)

15 August 2017

1 reference

title

Androgen treatment of depressive symptoms in older men: a systematic review of feasibility and effectiveness (English)

1 reference

15 August 2017

1 reference

Nathalie T Shamlian

1

1 reference

15 August 2017

Martin G Cole

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Canadian Journal of Psychiatry

15 August 2017

published in

1 reference

15 August 2017

volume

51

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

295-299

1 reference

Consequences of major and minor depression in later life: a study of disability, well-being and service utilization.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Minor and major depression and the risk of death in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

The male menopause and mood: testosterone decline and depression in the aging male--is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Increased incidence of diagnosed depressive illness in hypogonadal older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Low testosterone levels in elderly men with dysthymic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Testosterone replacement therapy in HIV illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Dehydroepiandrosterone (DHEA) treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Dehydroepiandrosterone treatment of midlife dysthymia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370605100505

10.1177/070674370605100505

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference